Internal Medicine, Medical Oncology · Casper, WY
NPI
1740700798
Since 2017
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6501 E 2nd St
Casper, WY, 82609
Phone (307) 235-5433
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.7M
276,239 services
Medicare patients, 2024
622
Average age 74
Drug cost, 2024
$3.1M
1,518 prescriptions
Company payments, 2025
$7,120
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Iloabueke G Chineke was code J9271 (injection, pembrolizumab, 1 mg), 27,200 times for 20 patients. In total Iloabueke G Chineke billed 276,239 services in 176 codes, and Medicare paid $6.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 27,200 | 20 | $44.55 | $1.2M |
| J0185 Injection, aprepitant, 1 mg | Office | 25,740 | 46 | $1.35 | $35K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 16,790 | 12 | $0.05 | $901 |
| J0897 Injection, denosumab, 1 mg | Office | 15,120 | 40 | $20.67 | $312K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,550 | 16 | $0.11 | $1,302 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 8,006 | 64 | $0.10 | $818 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,695 | 73 | $0.09 | $334 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 3,385 | 67 | $0.71 | $2,403 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 3,187 | 12 | $32.01 | $102K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,662 | 14 | $36.42 | $97K |
| 85025 Blood Count | Office | 1,533 | 315 | $7.61 | $12K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,340 | 15 | $3.53 | $4,732 |
| Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg | Office | 1,308 | 39 | $257.50 | $337K |
| 80053 Clinical Chemistry | Office | 1,266 | 305 | $10.35 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,041 | 291 | $8.65 | $9,005 |
By year: 2023 $2.3M for 113,722 services; 2024 $6.7M for 276,239 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,533 | 315 | $7.61 | $12K |
| 80053 Clinical Chemistry | 1,266 | 305 | $10.35 | $13K |
| 36415 Venipuncture Blood Collection | 1,041 | 291 | $8.65 | $9,005 |
| 84443 Clinical Chemistry | 183 | 65 | $16.46 | $3,012 |
| 82378 Clinical Chemistry | 133 | 30 | $18.58 | $2,471 |
| 86300 Immunoassay | 86 | 32 | $20.39 | $1,754 |
| 83615 Clinical Chemistry | 82 | 51 | $5.92 | $485 |
| 82728 Clinical Chemistry | 80 | 38 | $13.36 | $1,069 |
| 84153 Clinical Chemistry | 74 | 18 | $18.02 | $1,333 |
| 86304 Immunoassay | 38 | 14 | $20.39 | $775 |
Medicare prescription drug claims, 2024
In 2024, the drug Iloabueke G Chineke prescribed most often to Medicare patients was Anastrozole, with 117 prescriptions and refills. In total Iloabueke G Chineke wrote 1,518 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 117 | 206 | 34 | $2,020 |
| Acyclovir Generic | 73 | 79 | 21 | $1,073 |
| Prochlorperazine Maleate Generic | 66 | 66 | 50 | $720 |
| Potassium Chloride Generic | 57 | 78 | 27 | $1,680 |
| Venclexta Venetoclax | 54 | 54 | Under 11 | $452K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 63 | 15 | $251 |
| Ondansetron Odt Ondansetron | 51 | 51 | 37 | $1,580 |
| Prednisone Generic | 47 | 53 | 21 | $272 |
| Duloxetine Hcl Generic | 46 | 50 | 14 | $686 |
| Ondansetron Hcl Generic | 43 | 43 | 28 | $371 |
| Allopurinol Generic | 39 | 59 | 13 | $227 |
| Dexamethasone Generic | 34 | 47 | 19 | $574 |
| Abiraterone Acetate Generic | 33 | 33 | Under 11 | $93K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 33 | 33 | 14 | $897 |
| Oxycodone Hcl Generic | 32 | 32 | 17 | $331 |
Brand drugs: 243 claims; generic drugs: 1,275 claims; opioid claims: 91.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Iloabueke G Chineke $7,120 ($7,120 in general payments such as food, travel and fees) from 44 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,076.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $3,076 |
| Daiichi Sankyo Inc. 4568.T | 10 | $739 |
| Pfizer Inc. PFE | 16 | $354 |
| Janssen Biotech, Inc. JNJ | 9 | $295 |
| Tempus AI, Inc TEM | 4 | $210 |
| Merck Sharp & Dohme LLC MRK | 9 | $177 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $165 |
| Kite Pharma, Inc. GILD | 2 | $149 |
| Exelixis Inc. EXEL | 2 | $145 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.